Pelosi’s Drug Bill Is A Hard Pill To Swallow
Pelosi’s Plan Blocks Price Increases On Existing Drugs. Since Drug Companies Operate On 10.5% Mark-Up, To Remain Profitable, They Will Have To Launch New Drugs At Even Higher Prices. They Will Also Have To Make Up For Lost Investment Capital From Foreign Countries Who Will Find The U.S. Drug Research Market Less Profitable. The U.S. Will Absorb Even More Of The Cost For Drug Development.
Read more